watch
Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


: | Frankfurt Stock Exchange: NB3 | Nasdaq: NBIX


Similar to: Recordati SpA, Ipsen SA, BioGaia AB

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Its product candidates address endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

News & Analysis

You may also be interested in: